(Q30838330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

C Gaudy-Marqueste

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

R Carron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Delsanti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Loundou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Monestier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

E Archier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M A Richard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

J Regis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

23 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

2086-2091

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25057167%20AND%20SRC:MED&resulttype=core&format=json

Stereotactic radiosurgery in the treatment of brain metastases: the current evidence.

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Vemurafenib and radiosensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Vemurafenib and radiation therapy in melanoma brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

An integrated logistic formula for prediction of complications from radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266

Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU266